09.28.20Risdiplam Improves Motor Function in Infants with Type 1 SMA
09.23.20Individuals with Parkinson Disease More Likely to Have Orthostatic Hypotension
09.18.20One-Time Gene Therapy Delivered Neurosurgically Delivered to Striatum Provided Sustained Motor Function Improvements in Parkinson Disease
Trending Autoantibodies Causing Movement Disorders
As new autoantibodies are described, the field of autoimmune movement disorders is ever expanding.
F. Stephen Benesh, MD, and Shruti P. Agnihotri, MD
Immune-Mediated Cerebellar Ataxias
Cerebellar ataxia may be a prominent feature in autoimmune encephalitis and paraneoplastic syndromes.
Fabio Fieni Toso, MD; Rene de Araújo Gleizer, MD; and Lívia Almeida Dutra, MD, PhD
Treatment consists of immunomodulatory therapies and symptom management.
Jakai D. Nolan, DO, MPH, and Jacqueline A. Nicholas, MD, MPH
Movement Disorders in Antiphospholipid Syndrome & Systemic Lupus Erythematosus
Several movement disorders are seen with APS and SLE, most commonly chorea.
Danielle S. Shpiner, MD; Crystal Dixon, MD; Melissa R. Ortega, MD; and Henry Moore, MD
Anti-N-Methyl D Aspartate Receptor Encephalitis
Encephalitis caused by antibodies to the N-methyl-D-aspartate receptor causes symptoms of movement disorders, seizure, and psychiatric disturbances.
Nidhiben Anadani, MD
Utility of Autoantibody Profiles
Algorithmic testing for autoantibody profiles is more sensitive than physician-selected single autoantibody testing.
Shailee S. Shah, MD, and Andrew McKeon, MD
Autoimmune Movement Disorders in Children
A clinical approach.
Monideep Dutt, MD; Jamika Hallman-Cooper, MD; Ekta Bery, MD; Mohammed Shahnawaz, MD; and Grace Gombolay, MD
Autoimmune Movement Disorders in Adults
As antibodies to neuronal targets are described, we see the clinical spectrum and pathophysiology of autoimmune movement disorders more clearly.
Bettina Balint, MD
Guest Medical Editor's Page
Autoimmune Movement Disorders
Autoimmune movement disorders remind us to learn from our history.
Jill M. Giordano Farmer, DO
08.27.20Cerebral Dopamine Neurotrophic Factor Found Safe and Tolerable and May Improve Motor Function in Parkinson Disease
08.26.20Virtual Programs and Events Available to Support PD Community Through Ongoing COVID-19 Pandemic
08.19.20Healthy Diet May Reduce Nonmotor Symptoms of Prodromal Parkinson Disease
07.23.20FDA Approves iOS-Compatible App for Individuals With Chronic Pain and Movement Disorders to Personalize Therapy
07.20.20Parkinson's Disease and COVID-19 Patient Reported Outcomes on Fox Insight